NCT05055466View on ClinicalTrials.gov

COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)

CompletedOBSERVATIONAL
Enrollment

283

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

September 30, 2023

Conditions
SARS-CoV-2 InfectionCovid19Intestinal Infection
Trial Locations (4)

1090

St.Anna Children´s Hospital, Vienna

Unknown

University Hospital Krems, Krems

University Hospital Tulln, Tulln

Klinik Ottakring, Vienna

All Listed Sponsors
lead

St. Anna Kinderkrebsforschung

OTHER

NCT05055466 - COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS) | Biotech Hunter | Biotech Hunter